A randomized trial comparing intravitreal triamcinolone and focal/grid photocoagulation for diabetic macular edema: baseline features.
Jan 01 2023
PubMed ID: 18698292 Author(s): Ip MS, Bressler SB, Antoszyk AN, Flaxel CJ, Kim JE, Friedman SM, Qin H; Diabetic Retinopathy Clinical Research Network. A randomized trial comparing intravitreal triamcinolone and focal/grid photocoagulation for diabetic macular…
Read MoreOptical coherence tomography findings in central retinal artery occlusion.
Jan 01 2023
PubMed ID: 17152548 Author(s): Falkenberry SM, Ip MS, Blodi BA, Gunther JB. Optical coherence tomography findings in central retinal artery occlusion. Ophthalmic Surg Lasers Imaging. 2006 Nov-Dec;37(6):502-5. doi: 10.3928/15428877-20061101-12. PMID 17152548 Journal: Ophthalmic Surgery, Lasers…
Read MoreResponse to aflibercept in patients with persistent exudation despite prior treatment with bevacizumab or ranibizumab for age-related macular degeneration.
Jan 01 2023
PubMed ID: 25230402 Author(s): Eadie JA, Gottlieb JL, Ip MS, Blodi BA, Danis RP, Chandra SR, Nork TM, Altaweel MM, Stern-Hogan BS. Response to aflibercept in patients with persistent exudation despite prior treatment with bevacizumab…
Read MoreTwo discrete uveal melanomas in a child with ocular melanocytosis.
Jan 01 2023
PubMed ID: 16829813 Author(s): Shields CL, Eagle RC, Ip MS, Marr BP, Shields JA. Two discrete uveal melanomas in a child with ocular melanocytosis. Retina. 2006 Jul-Aug;26(6):684-7. PMID 16829813 Journal: Retina (Philadelphia, Pa.), Volume 26,…
Read MoreSCORE2 Report 2: Study Design and Baseline Characteristics.
Feb 01 2017
PubMed ID: 27863843 Author(s): Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, Figueroa M, Dugel PU; SCORE2 Investigator Group. SCORE2 report 2: study design and baseline characteristics. Ophthalmology. 2017 Feb;124(2):245-256. doi: 10.1016/j.ophtha.2016.09.038. Epub…
Read MoreSCORE2 Report 1: Techniques to Optimize Recruitment in Phase III Clinical Trials of Patients With Central Retinal Vein Occlusion.
Oct 01 2016
PubMed ID: 27450625 Author(s): Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, Figueroa M; SCORE2 Investigator Group. SCORE2 report 1: techniques to optimize recruitment in Phase III clinical trials of patients with central…
Read MoreReply.
Feb 01 2016
PubMed ID: 26696314 Author(s): Eadie JA, Ip MS. Reply. Retina. 2016 Feb;36(2):e10-2. doi: 10.1097/IAE.0000000000000918. PMID 26696314 Journal: Retina (Philadelphia, Pa.), Volume 36, Issue 2, Feb 2016
Read MoreIncidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion: SCORE Study Report 15.
Sep 01 2015
PubMed ID: 26086920 Author(s): Aref AA, Scott IU, Oden NL, Ip MS, Blodi BA, VanVeldhuisen PC; SCORE Study Investigator Group. Incidence, risk factors, and timing of elevated intraocular pressure after intravitreal triamcinolone acetonide injection for…
Read MoreReply: To PMID 24999721.
Aug 01 2015
PubMed ID: 26166802 Author(s): Eadie JA, Ip MS. Reply: To PMID 24999721. Retina. 2015 Aug;35(8):e54-5. doi: 10.1097/IAE.0000000000000682. PMID 26166802 Journal: Retina (Philadelphia, Pa.), Volume 35, Issue 8, Aug 2015
Read More